Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.43% | 32.26% | 60.62% | 102.10% | 103.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.43% | 32.26% | 60.62% | 102.10% | 103.89% |
| Cost of Revenue | 8.54% | 43.90% | 76.28% | 146.37% | 180.89% |
| Gross Profit | 22.35% | 26.71% | 53.39% | 84.18% | 77.06% |
| SG&A Expenses | 17.42% | 27.34% | 52.12% | 87.73% | 89.63% |
| Depreciation & Amortization | 17.49% | 55.70% | 133.92% | 328.90% | 463.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.51% | 31.04% | 62.35% | 116.30% | 130.60% |
| Operating Income | 66.13% | 39.16% | 51.70% | 43.03% | 12.35% |
| Income Before Tax | 461.28% | 148.76% | -27.01% | -40.23% | -74.54% |
| Income Tax Expenses | -34.73% | 75.38% | -58.28% | -33.79% | -54.69% |
| Earnings from Continuing Operations | 776.83% | 178.51% | -16.19% | -42.05% | -80.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 776.83% | 178.51% | -16.19% | -42.05% | -80.09% |
| EBIT | 66.13% | 39.16% | 51.70% | 43.03% | 12.35% |
| EBITDA | 45.11% | 41.69% | 60.42% | 82.00% | 58.93% |
| EPS Basic | 775.77% | 112.87% | -35.88% | -57.22% | -85.30% |
| Normalized Basic EPS | 54.71% | 12.84% | -1.73% | -1.69% | -23.17% |
| EPS Diluted | 796.24% | 112.66% | -35.72% | -57.31% | -85.57% |
| Normalized Diluted EPS | 53.41% | 11.76% | -1.76% | -1.00% | -22.44% |
| Average Basic Shares Outstanding | 4.28% | 11.73% | 20.09% | 31.36% | 30.40% |
| Average Diluted Shares Outstanding | 5.21% | 12.84% | 20.05% | 30.37% | 29.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |